Keywords: schering, ag, starts, betaferon, trial, early, ms

Schering AG starts Betaferon trial early MS

Article | 11 March 2002

Print This

Schering AG of Germany has initiated a new Phase III study of itsmultiple sclerosis drug Betaferon/Betaseron (interferon alfa-2b) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in